CBLL

CeriBell, Inc. Common Stock

27.48

USD

-0.12

-0.43%

Nov 10, 15:59 UTC -5

Closed

After-Market

27.49

+0.01

+0.04%

CeriBell, Inc. Common Stock (CBLL) Earnings

CBLL Earnings Reports

Positive Surprise Ratio

CBLL beat 5 of 9 last estimates.

56%

Next Report

Date of Next Report

Feb 22, 2027

Estimate for Q4 26 (Revenue/ EPS)

$32.53M

-$0.44

Implied change from Q3 26 (Revenue/ EPS)

+10.86%

-13.73%

Implied change from Q4 25 (Revenue/ EPS)

+31.24%

+22.22%

CeriBell, Inc. Common Stock earnings per share and revenue

On Nov 03, 2026, CBLL reported earnings of -0.51 USD per share (EPS) for Q3 26, beating the estimate of -0.52 USD, resulting in a 1.96% surprise. Revenue reached 29.34 million, compared to an expected 29.75 million, with a -1.36% difference. The market reacted with a -3.11% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of -0.44 USD, with revenue projected to reach 32.53 million USD, implying an decrease of -13.73% EPS, and increase of 10.86% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Lumexa Imaging Holdings, Inc. Common Stock

Report Date

Nov 10, 2026 For Q3 26

Estimate

$0.18

Actual

$0.26

Surprise

+39.63%

Capricor Therapeutics Inc

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$0.44

Actual

-$0.73

Surprise

-65.16%

Village Farms International, Inc. Common Shares

Report Date

Nov 09, 2026 For Q3 26

Estimate

$0.05

Actual

$0.08

Surprise

+48.42%

Canopy Growth Corporation Common Shares

Report Date

Nov 06, 2026 For Q2 27

Estimate

-$0.03

Actual

-$0.01

Surprise

+71.75%

OraSure Technologies Inc

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.20

Actual

-$0.15

Surprise

+28.26%

TriSalus Life Sciences, Inc. Common Stock

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$0.13

Actual

-$0.15

Surprise

-14.85%

Exagen Inc. Common Stock

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$0.18

Actual

-$0.25

Surprise

-35.35%

Quanterix Corporation Common Stock

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.44

Actual

-$0.46

Surprise

-3.67%

Prestige Consumer Healthcare Inc.

Report Date

Nov 05, 2026 For Q2 27

Estimate

$1.08

Actual

$1.12

Surprise

+4.28%

Myomo Inc.

Report Date

Nov 09, 2026 For Q3 26

Estimate

-$0.07

Actual

-$0.07

Surprise

+11.17%

FAQ

What were CeriBell, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, CeriBell, Inc. Common Stock reported EPS of -$0.51, beating estimates by 1.96%, and revenue of $29.34M, -1.36% below expectations.

How did the market react to CeriBell, Inc. Common Stock's Q3 2026 earnings?

The stock price moved down -3.11%, changed from $28.27 before the earnings release to $27.39 the day after.

When is CeriBell, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 22, 2027.

What are the forecasts for CeriBell, Inc. Common Stock's next earnings report?

Based on -- analysts, CeriBell, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of $32.53M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.